Stay updated on VB-111 Combo in Recurrent Glioblastoma Clinical Trial
Sign up to get notified when there's something new on the VB-111 Combo in Recurrent Glioblastoma Clinical Trial page.

Latest updates to the VB-111 Combo in Recurrent Glioblastoma Clinical Trial page
- Check4 days agoChange DetectedLocations were expanded to include new sites across Alabama, Arizona, California, Colorado, District of Columbia, Florida, Georgia, Illinois, Kansas, Kentucky, Louisiana, Massachusetts, Michigan, Minnesota, Missouri, New Hampshire, New York, North Carolina, Pennsylvania, Texas, Utah, Virginia, Washington, Wisconsin, Alberta, and Ontario. The page revision updated to v3.3.3 and the HHS Vulnerability Disclosure link was removed.SummaryDifference2%

- Check12 days agoNo Change Detected
- Check19 days agoNo Change Detected
- Check33 days agoChange DetectedPublication information now notes that PubMed publications are automatically filled from PubMed and may not be about the study. Revision: v3.3.2.SummaryDifference0.1%

- Check40 days agoChange DetectedThe funding/operating-status notice on the page has been removed. The study details and other content remain unchanged.SummaryDifference0.3%

- Check48 days agoChange DetectedThe 'Official Globe Trial Website' link was removed from the Study Details page (NCT02511405), removing a primary external resource for accessing the official trial information.SummaryDifference0.0%

- Check55 days agoChange DetectedNo substantial changes detected in the study details or locations between versions. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check84 days agoChange Detected- Added a government operations notice and operating details, plus a new v3.2.0 revision. - Removed the previous v3.1.0 revision.SummaryDifference4%

Stay in the know with updates to VB-111 Combo in Recurrent Glioblastoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the VB-111 Combo in Recurrent Glioblastoma Clinical Trial page.